North America Pharmaceutical Excipients Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Pharmaceutical Excipients are substances other than pharmacologically active drug components, which are included in the drug manufacturing process or contained in a finished pharmaceutical product dosage form. They facilitate formulation design and perform a range of functions such as enhancing flowability, increasing lubricity, improving compressibility, etc.

North America Pharmaceutical Excipients Market Segments Size & Growth:

North America pharmaceutical excipients market size is projected to reach approximately $3.95 billion by the end of 2024 with a CAGR of close to 5.78% from $1.95 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include a rise in the incidence of diseases which has increased the demand for drugs, inventions of new excipients in the pharma industry and advancements in the techniques and equipment manufacturing excipients. However, Risk of adverse reactions on the body and stringent FDA guidelines for approval are thereby hampering the market growth.

North America Pharmaceutical Excipients Market Segments Share:

North America pharmaceutical excipients market is categorised into Process which comprise Diluents, Binders, Disintegrants, Glidants, Lubricants, Flavoring agents, Coloring agents and Coatings & Films. By Type of Product, the market is segmented into Organic and Inorganic Chemicals. Among these Organic chemicals, segment accounted for the largest share of the pharmaceutical excipients market, followed by inorganic chemicals. The large share of Organic Chemicals can be attributed to the wide applications in the manufacturing of pharmaceutical drugs. By Geography, USA is projected to dominate the market with the largest share and the growth in the North America economies is mainly attributed because of huge profit margins and growth prospects.

North America Pharmaceutical Excipients Market Trends:

• SIO, an Archer Daniels Midland Company, presented a new range of innovative products and capabilities at CPhI 2016 in Barcelona.
• Merck Millipore, a leading science, and technology company, announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.
• FMC Corporation announced the signing of a definitive agreement with Nufarm Limited to divest a portion of FMC’s European herbicide portfolio.

North America Pharmaceutical Excipients Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

• Ashland Inc.
• AkzoNobel
• Archer Daniels Midland Company
• Associated British Foods PLC
• BASF SE